BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11745869)

  • 1. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
    Kanerva J; Niini T; Vettenranta K; Riikonen P; Mäkipernaa A; Karhu R; Knuutila S; Saarinen-Pihkala UM
    Med Pediatr Oncol; 2001 Nov; 37(5):419-25. PubMed ID: 11745869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
    Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
    Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic and FISH findings are complementary in childhood ALL].
    Haltrich I; Csóka M; Kovács G; Fekete G
    Magy Onkol; 2008 Sep; 52(3):283-91. PubMed ID: 18845499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
    Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
    Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally.
    Wiemels JL; Hofmann J; Kang M; Selzer R; Green R; Zhou M; Zhong S; Zhang L; Smith MT; Marsit C; Loh M; Buffler P; Yeh RF
    Cancer Res; 2008 Dec; 68(23):9935-44. PubMed ID: 19047175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
    Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
    Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
    Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
    Niu C; Huang W; Su X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
    Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study.
    Ma SK; Wan TS; Cheuk AT; Fung LF; Chan GC; Chan SY; Ha SY; Chan LC
    Leukemia; 2001 Sep; 15(9):1442-7. PubMed ID: 11516105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.
    Iqbal Z
    Asian Pac J Cancer Prev; 2014; 15(8):3541-6. PubMed ID: 24870754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.